Lineage-dependent effects of aryl hydrocarbon receptor agonists contribute to liver tumorigenesis

Hepatology

Volumn 61, Issue 2, 2015, Pages 548-560

  Harrill, Joshua A ^a   Parks, Bethany B ^a   Wauthier, Eliane ^b   Rowlands, J Craig ^c   Reid, Lola M ^b   Thomas, Russell S ^a  

^a HAMNER INSTITUTES FOR HEALTH SCIENCES   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c DOW CHEMICAL COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 3,3' DIINDOLYLMETHANE; 6 FORMYLINDOLO [3,2 B] CARBAZOLE; AROMATIC HYDROCARBON; CARBAZOLE DERIVATIVE; CYTOCHROME P450 1A1; HYALURONIC ACID; LEUKEMIA INHIBITORY FACTOR; UNCLASSIFIED DRUG; AROMATIC HYDROCARBON RECEPTOR;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL LINEAGE; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; ENDODERM; GENE EXPRESSION; GENE INDUCTION; IMAGE ANALYSIS; IMMUNOCYTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER DEVELOPMENT; MULTIPOTENT STEM CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; STEM CELL EXPANSION; AGONISTS; ANIMAL; CARCINOGENESIS; CELL CULTURE; CHEMICALLY INDUCED; DRUG EFFECTS; LIVER TUMOR; SPRAGUE DAWLEY RAT; STEM CELL;

ANIMALS; CARCINOGENESIS; CELL LINEAGE; CELLS, CULTURED; HYALURONIC ACID; LEUKEMIA INHIBITORY FACTOR; LIVER NEOPLASMS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ARYL HYDROCARBON; STEM CELLS; TETRACHLORODIBENZODIOXIN;

EID: 84921532538     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.27547     Document Type: Article

References (42)

1. Denison MS, Soshilov AA, He G, DeGroot DE, Zhao B. Exactly the same but different: promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor. Toxicol Sci 2011;124:1-22.
2. Kolluri SK, Weiss C, Koff A, Gottlicher M. Induction and inhibition of prolieration by the intracellular Ah receptor in developing thymus and heptoma cells. Genes Dev 1999;13:1742-1753.
3. Ma Q, Baldwin KT, Renzelli AJ, McDaniel A, Dong L. TCDD-inducible poly (ADP-ribose) polymerase: a novel response to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin. Biochem Biophys Res Commun 2001;289:499-506.
4. Nguyen LP, Bradfield CA. The search for endogenous activators of the aryl hydrocarbon receptor. Chem Res Toxicol 2008;21:102-116.
5. Schroeder JC, Dinatale BC, Murray IA, Flaveny CA, Liu Q, Laurenzana EM, et al. The uremic toxin 3-indoxyl sulfate is a potent endogenous agonist of the human aryl hydrocarbon receptor. Biochemistry 2010;49:393-400.
6. Fernandez-Salguero PM, Hilbert DM, Rudikoff S, Ward JM, Gonzalez FJ. Aryl-hydrocarbon receptor-deficient mice are resistant to 2, 3, 7.8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicol Appl Pharmacol 1996;140:173-179.
7. Peters JM, Narotsky MG, Elizondo G, Fernandez-Salguero PM, Gonzalez FJ, Abbott BD. Amelioration of TCDD-induced teratogenesis in aryl hydrocarbon receptor (AhR)-null mice. Toxicol Sci 1999;47.
8. NTP Technical Report on the Toxicology and Carcinogenesis Studies of 2, 3, 7, 8, -Tetrachlorodibenzo-p-dioxin (TCDD) in Female Harlan Sprague-Dawley Rats. National Toxicology Program Technical Report Series 2006;5:4-232.
9. Kociba RJ, Keyes DG, Beyer JE, Carreon RM, Wade CE, Dittenber DA, et al. Results of a two-year chornic toxicity and oncogenicityi study of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin in rats. Toxicol Appl Pharmacol 1978;46:279-303.
10. Feng S, Cao Z, Wang X. Role of aryl hydrocarbon receptor in cancer. Biochim Biophys Acta 2013;1836:197-210.
11. Budinsky RA, Schrenk D, Simon T, Van den Berg M, Reichard JF, Silkworth JB, et al. Mode of action and dose-response framework analysis for receptor-mediated toxicity: the aryl hydrocarbon receptor as a case study. Crit Rev Toxicol 2014;44:83-119.
12. Cardinale V, Wang Y, Carpino G, Cui CB, Gatto M, Rossi M, et al. Multipotent stem cells in the extrahepatic biliary tree give rise to hepatocytes, bile ducts and pancreatic islets. Hepatology 2011;54:2159-2172.
13. Schmelzer E, Zhang L, Bruce A, Wauthier E, Ludlow J, Yao HL, et al. Human hepatic stem cells from fetal and postnatal donors. J Exp Med 2007;204:1973-1987.
14. Turner R, Lozoya O, Wang YF, Cardinale V, Gaudio E, Alpini G, et al. Hepatic stem cells and maturational liver lineage biology. Hepatology 2011;53:1035-1045.
15. Wang Y, Yao H, Cui C, Wauthier E, Barbier C, Costello M, et al. Paracrine signals from mesenchymal cell populations govern the expansion and differentiation of human hepatic stem cells to adult liver fates. Hepatology 2010;52:1443-1454.
16. Furth ME, Wang Y, Cardinale V, Carpino G, Lanzoni G, Cui C, et al. Stem cell populations giving rise to liver, biliary tree and pancreas. In: Sell S, editor. The stem cells handbook, 2nd ed. New York: Springer Science Publishers; 2013. p 75-126.
17. Cardinale V, Wang Y, Gaudio E, Mendel G, Alpini G, Gaudio E, et al. The biliary tree: a reservoir of multipotent stem cells. Nat Rev Gastroenterol Hepatol 2012;9:231-240.
18. Tsao MS, Smith JD, Nelson KG, Grisham JW. A diploid epiothelial cell line from normal adult rat liver with phenotypic properties of 'oval' cells. Exp Cell Res 1984;154:38-52.
19. Dietrich C, Faust D, Budt S, Moskwa A, Kunz A, Bock K, et al. 2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin-dendent release from contact inhibition in WB-F344 cells: involvement of cyclin A. Toxicol Appl Pharmacol 2002;183:117-126.
20. Prochazkova J, Kabatkova M, Bryja V, Umannová L, Bernatík O, Kozubík A, et al. The interplay of the aryl hydrocarbon receptor and bveta-catenin alters both AhR-dependent transcription and Wnt/beta-catenin signaling in liver progenitors. Toxicol Sci 2011;122:249-360.
21. Umannova L, Zatloukalova J, Machala M, Krcmár P, Májková Z, Hennig B, et al. Tumor necrosis factor-alpha modulates effects of arylo hydrocarbon receptor ligands on cell proliferation and expression of cytochrome P450 enzymes in rat liver "stem-like" cells. Toxicol Sci 2007;99:79-89.
22. Kubota H, Reid LM. Clonogenic hepatoblasts, common precursors for hepatocytic and biliary lineages, are lacking classical major histocompatibility complex class I antigens. Proc Natl Acad Sci U S A 2000;97:12132-12137.
23. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C (T)) method. Methods 2001;25:402-408.
24. Barbaric I, Gokhale PJ, Jones M, Glen A, Baker D, Andrews PW. Novel regulators of stem cell fates identified by a multivariate phenotype screen of small compounds on human embryonic stem cell colonies. Stem Cell Res 2010;5:104-119.
25. Kubota H, Yao H, Reid LM. Identification and characterization of vitamin A-storing cells in fetal liver. Stem Cell 2007;25:2339-2349.
26. Darzynkiewicz Z, Balaszs EA. Genome integrity, stem cells and hyaluronan. Aging 2012;4:78-88.
27. Goodison S, Urquidi V, Tarin D. CD44 cell adhesion molecules. Mol Pathol 1999;52:189-196.
28. Schmidt DS, Klingbell P, Schnolzer M, Zoller M. CD44 variant isoforms associate with tetraspanins and EpCAM. Exp Cell Res 2004;297:329-347.
29. Hirohashi K, Yamamoto T, Uenishi T, Ogawa M, Sakabe K, Takemura S, et al. CD44 and VEGF expression in extrahepatic metastasis of human hepatocellular carcinoma. Hepatogastroenterology 2004;51:1121-1123.
30. Kuhn S, Koch M, Nubel T, Ladwein M, Antolovic D, Klingbeil P, et al. A complex of EpCAM, claudin-7, CD44 variant isoforms, and tetraspanins promotes colorectal cancer progression. Mol Cancer Res 2007;5:553-567.
31. Yang GH, Fan J, Xu Y, Qiu SJ, Yang XR, Shi GM, et al. Osteopontin combined with CD44, a novel prognostic biomarker for patients with hepatocellular carcinoma undergoing curative resection. Oncologist 2008;13:1155-1165.
32. Ogawa M, Yamamoto T, Kubo S, Uenishi T, Tanaka H, Shuto T, et al. Clinicopathologic analysis of risk factors for distant metastasis of hepatocellular carcinoma. Hepatol Res 2004;29:228-234.
33. Wang M, Xiao J, Shen M, Yahong Y, Tian R, Zhu F, et al. Isolation and characterization of tumorigenic extrahepatic cholangiocarcinoma cells with stem cell-like properties. Int J Cancer 2011;128:72-81.
34. Chiu CC, Sheu JC, Chen CH, Lee CZ, Chiou LL, Chou SH, et al. Global gene expression profiling reveals a key role of CD44 in hepatic oval-cell reaction after 2-AAF/CCl4 injury in rodents. Histochem Cell Biol 2009;132:479-489.
35. Hirai H, Firpo M, Kikyo N. Establishment of LIF-dependent human iPS cells closely related to basic FGF-dependent authetic iPS cells. PLoS One 2012;7:e39022.
36. Hilton DJ, Nicola NA, Waring PM, Metcalf D. Clearance and fate of leukemia-inhibitory factor (LIF) after injection into mice. J Cell Physiol 1991;148:430-349.
37. Omori N, Evarts RP, Omori M, Hu Z, Marsden ER, Thorgeirsson SS. Expression of leukemia inhibitory factor and its receptor during liver regeneration in the adult rat. Lab Invest 1996;75:15-24.
38. Bergander L, Wincent E, Rannug A, Foroozesh M, Alworth W, Rannug U. Metabolic fate of the Ah receptor ligand 6-formylindolo[3, 2-b] carbazole. Chem Biol Interact 2004;149:151-164.
39. Pollenz RS, Santostefano MJ, Klett E, Richardson VM, Necela B, Birnbaum LS. Female Sprague-Dawley rats exposed to a single oral dose of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin exhibit sustained depeletion of aryl hydrocarbon receptor protein in liver, spleen, thymus and lung. Toxicol Sci 1998;42:117-128.
40. Wang Y, Lanzoni G, Carpino G, Cui CB, Dominguez-Bendala J, Wauthier E, et al. Biliary tree stem cells, precursors to pancreatic committed progenitors: evidence for life-long pancreatic organogenesis. Stem Cells 2013;31:1966-1979.
41. Weiss C, Faust D, Schreck I, Ruff A, Farwerck T, Melenberg A, et al. TCDD deregulates contact inhibition in rat liver oval cells via Ah receptor, JunD and cyclin A. Oncogene 2008;27:2198-2207.
42. Yimlamai D, Christodoulou C, Galli GG, Yanger K, Pepe-Mooney B, Gurung B, et al. Hippo pathway activity influences liver cell fate. Cell 2014;157:1324-1338.